These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 22162411

  • 1. Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.
    Barthélémy O, Silvain J, Brieger D, Mercadier A, Lancar R, Bellemain-Appaix A, Beygui F, Collet JP, Costagliola D, Montalescot G.
    Catheter Cardiovasc Interv; 2012 Jan 01; 79(1):104-12. PubMed ID: 22162411
    [Abstract] [Full Text] [Related]

  • 2. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.
    Siudak Z, Zawislak B, Dziewierz A, Rakowski T, Jakala J, Bartus S, Noworolnik B, Zasada W, Dubiel JS, Dudek D.
    Coron Artery Dis; 2010 Aug 01; 21(5):292-7. PubMed ID: 20453640
    [Abstract] [Full Text] [Related]

  • 3. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction.
    Vranckx P, Campo G, Anselmi M, Bolognese L, Colangelo S, Biondi-Zoccai G, Moreno R, Piva T, Favero L, Prati F, Nazzaro M, Díaz Fernández JF, Ferrari R, Valgimigli M, Multicenter Evaluation of Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study.
    EuroIntervention; 2012 May 15; 8(1):71-8. PubMed ID: 22311867
    [Abstract] [Full Text] [Related]

  • 4. Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study.
    Cayla G, Silvain J, Barthelemy O, Connor S', Payot L, Bellemain-Appaix A, Beygui F, Aout M, Collet JP, Vicaut E, Montalescot G, ABOARD investigators.
    Heart; 2011 Jun 15; 97(11):887-91. PubMed ID: 21421600
    [Abstract] [Full Text] [Related]

  • 5. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
    Bagur R, Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Nguyen CM, Noel B, Larochellière RD, Poirier P, Costerousse O, Roy L.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1010-6. PubMed ID: 19753635
    [Abstract] [Full Text] [Related]

  • 6. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE, Athar H, Henry TD, Larson DM, Simons M, Chan RS, Niles NW, Thiele H, Schuler G, Ahn C, Sdringola S, Anderson HV, McKay RG, Smalling RW.
    JACC Cardiovasc Interv; 2008 Oct 01; 1(5):504-10. PubMed ID: 19463352
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M, Borelli G, Gistri R, Ciabatti N, Mazzoni A, Arena M, Petronio AS.
    Catheter Cardiovasc Interv; 2009 Sep 01; 74(3):408-15. PubMed ID: 19360863
    [Abstract] [Full Text] [Related]

  • 8. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Dörler J, Edlinger M, Alber HF, Altenberger J, Benzer W, Grimm G, Huber K, Pachinger O, Schuchlenz H, Siostrzonek P, Zenker G, Weidinger F, Austrian Acute PCI Investigators.
    Eur Heart J; 2011 Dec 01; 32(23):2954-61. PubMed ID: 21920970
    [Abstract] [Full Text] [Related]

  • 9. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.
    Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, Holmes DR, Rihal CS.
    JACC Cardiovasc Interv; 2008 Apr 01; 1(2):202-9. PubMed ID: 19463301
    [Abstract] [Full Text] [Related]

  • 10. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry.
    Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K, EUROTRANSFER Registry Investigators.
    Am Heart J; 2008 Dec 01; 156(6):1147-54. PubMed ID: 19033011
    [Abstract] [Full Text] [Related]

  • 11. Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.
    Brieger D, Collet JP, Silvain J, Landivier A, Barthélémy O, Beygui F, Bellemain-Appaix A, Mercadier A, Choussat R, Vignolles N, Costagliola D, Montalescot G.
    Catheter Cardiovasc Interv; 2011 Feb 01; 77(2):182-90. PubMed ID: 20578166
    [Abstract] [Full Text] [Related]

  • 12. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
    Nikolsky E, Sadeghi HM, Effron MB, Mehran R, Lansky AJ, Na Y, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD, Grines CL, Stone GW.
    Am J Cardiol; 2005 Aug 15; 96(4):474-81. PubMed ID: 16098296
    [Abstract] [Full Text] [Related]

  • 13. Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials.
    De Luca G, Verdoia M, Suryapranata H.
    Atherosclerosis; 2012 Jun 15; 222(2):426-33. PubMed ID: 22483166
    [Abstract] [Full Text] [Related]

  • 14. Comparison of procedural times, success rates, and safety between left versus right radial arterial access in primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Larsen P, Shah S, Waxman S, Freilich M, Riskalla N, Piemonte T, Jeon C, Pyne C.
    Catheter Cardiovasc Interv; 2011 Jul 01; 78(1):38-44. PubMed ID: 20939041
    [Abstract] [Full Text] [Related]

  • 15. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.
    Herrmann HC, Lu J, Brodie BR, Armstrong PW, Montalescot G, Betriu A, Neuman FJ, Effron MB, Barnathan ES, Topol EJ, Ellis SG, FINESSE Investigators.
    JACC Cardiovasc Interv; 2009 Oct 01; 2(10):917-24. PubMed ID: 19850249
    [Abstract] [Full Text] [Related]

  • 16. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W, Vyas A, Giacomino B, Schweizer M, Blevins A, Girotra S, Horwitz PA.
    JACC Cardiovasc Interv; 2013 Aug 01; 6(8):814-23. PubMed ID: 23968700
    [Abstract] [Full Text] [Related]

  • 17. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
    Lenderink T, Boersma E, Ruzyllo W, Widimsky P, Ohman EM, Armstrong PW, Wallentin L, Simoons ML, GUSTO IV-ACS Investigators.
    Am Heart J; 2004 May 01; 147(5):865-73. PubMed ID: 15131544
    [Abstract] [Full Text] [Related]

  • 18. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry).
    Dziewierz A, Mielecki W, Siudak Z, Rakowski T, Janzon M, Birkemeyer R, Zasada W, Dubiel JS, Dudek D.
    Atherosclerosis; 2012 Jul 01; 223(1):212-8. PubMed ID: 22658254
    [Abstract] [Full Text] [Related]

  • 19. Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab.
    Philippe F, Larrazet F, Meziane T, Dibie A.
    Catheter Cardiovasc Interv; 2004 Jan 01; 61(1):67-73. PubMed ID: 14696162
    [Abstract] [Full Text] [Related]

  • 20. Bleeding outcomes after routine transradial primary angioplasty for acute myocardial infarction using eptifibatide and unfractionated heparin: a single-center experience following the HORIZONS-AMI trial.
    Moody WE, Chue CD, Ludman PF, Chan YK, Narayan G, Millington JM, Townend JN, Doshi SN.
    Catheter Cardiovasc Interv; 2013 Sep 01; 82(3):E138-47. PubMed ID: 23074143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.